Abbasi F, Brown BW, Lamendola C, McLaughlin T, Reaven GM (2002). Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40, 937-43.
Bilgili S, Celebiler AC, Doğan A, Karaca B (2008). Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients. Endocr Regul 42, 63-68.
Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CWJr (1999). Body-mass index and mortality in a prospective cohort of US adults. New Engl J Med 341, 1097-1105.
Carey VJ, Walters EE, Colditz GA, Solomon CG, Willet WC, Rosner BA, Speizer FE, Manson JE (1997). Body fat distribution and risk noninsulin-dependent diabetes mellitus in women. The Nurses’ Health Study. Am J Epidemiol 145, 614-619.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Ohannesian JP, Marco CC, McKee LJ, Bauer TL (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl J Med 334, 292-295.
Gaudet D, Vohl MC, Perron P, Tremblay G, Gagn C, Lesiege D, Bergeron J, Moorjani S, Despres JP (1998). Relationships of abdominal obesity and hyper- insulinemi to angiographically assesed coronary artery disease in men with known mutations in the LDL receptor gene. Circulation 97, 871-877.
Hubert HB (1986). The importance of obesity in the development of coronary risk factors and disease: The epidemiologic evidence. Annu Rev Publ Health 7, 493-502.
Jousilahti P, Tuomilehto J, Vartiainene E, Pekkanen J, Puska P (1996). Body weight, cardiovascular risk factors, and coronary mortality. Circulation 93, 1372-1379.
Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP (1997). Varying body mass index cutoff points to describe overweight prevalence among US adults: NHANES III (1988 to 1994). Obes Res 5, 542-548.
Ludvic B, Nolan JJ, Baloga J, Sacks D, Olefsky J (1995). Effect of obesity on insulin resistance in normal subject and patients with NIDDM. Diabetes 44, 1121-1125.
Onat A (2003). The impact of obesity on cardiovasculer disease in Turkey. Turk Soc Cardiol 31, 279-289.
Racette SB, Deusinger SS, Deusinger RH (2003). Obesity: overview of prevalence, etiology, and treatment. Phys Ther 83, 276-288.
Reaven GM, Chem YDI (1998). Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 4, 639-652.
Sarlio-Lahteenkorva S, Lahelma E (1999). The ascociation of body mass index with social and economic disadvantage in women and men. Int J Epidemiol 28, 445-449.
Seidell JC, Verschuren M, Van Leer E, Kromhout D (1996). Overweight, underweight and mortality. Arch Intern Med 156, 958-963.
WHO Global Database on BMI. (2007). Available from: URL: http://www.who.int/bmi/index.jsp?introPage= intro_3.html.
WHO (2011). Obesity: preventing and managing the global epidemic report on a WHO consultation. Technical Report Series, No: 894, World Health Organization, No: 311.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, Interheart Study Investigators (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the Interheart study): case-control study. Lancet 364, 937-995.
Thank you for copying data from http://www.arastirmax.com
